Literature DB >> 32174044

A review of recent research on Theileria parva: Implications for the infection and treatment vaccination method for control of East Coast fever.

Richard P Bishop1, David Odongo2, Jabbar Ahmed3, Micky Mwamuye3, Lindsay M Fry1,4, Donald P Knowles1, Anne Nanteza5, George Lubega5, Paul Gwakisa6, Peter-Henning Clausen3, Isaiah Obara3.   

Abstract

The infection and treatment (ITM) live vaccination method for control of Theileria parva infection in cattle is increasingly being adopted, particularly in Maasai pastoralist systems. Several studies indicate positive impacts on human livelihoods. Importantly, the first detailed protocol for live vaccine production at scale has recently been published. However, quality control and delivery issues constrain vaccination sustainability and deployment. There is evidence that the distribution of T. parva is spreading from endemic areas in East Africa, North into Southern Sudan and West into Cameroon, probably as a result of anthropogenic movement of cattle. It has also recently been demonstrated that in Kenya, T. parva derived from cape buffalo can 'breakthrough' the immunity induced by ITM. However, in Tanzania, breakthrough has not been reported in areas where cattle co-graze with buffalo. It has been confirmed that buffalo in northern Uganda national parks are not infected with T. parva and R. appendiculatus appears to be absent, raising issues regarding vector distribution. Recently, there have been multiple field population genetic studies using variable number tandem repeat (VNTR) sequences and sequencing of antigen genes encoding targets of CD8+ T-cell responses. The VNTR markers generally reveal high levels of diversity. The antigen gene sequences present within the trivalent Muguga cocktail are relatively conserved among cattle transmissible T. parva populations. By contrast, greater genetic diversity is present in antigen genes from T. parva of buffalo origin. There is also evidence from several studies for transmission of components of stocks present within the Muguga cocktail, into field ticks and cattle following induction of a carrier state by immunization. In the short term, this may increase live vaccine effectiveness, through a more homogeneous challenge, but the long-term consequences are unknown.
© 2020 Blackwell Verlag GmbH.

Entities:  

Keywords:  zzm321990Theileria parvazzm321990; East Coast fever; cape buffalo; infection and treatment (ITM); live vaccination; molecular epidemiology; population genetics

Year:  2020        PMID: 32174044     DOI: 10.1111/tbed.13325

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  9 in total

1.  Molecular epidemiology and genetic characterization of Theileria orientalis in cattle.

Authors:  Abdelfattah Selim; Kotb Attia; Muneera D F AlKahtani; Fatima M Albohairy; Salma Shoulah
Journal:  Trop Anim Health Prod       Date:  2022-05-05       Impact factor: 1.559

2.  Detection of Tick-Borne Bacterial and Protozoan Pathogens in Ticks from the Zambia-Angola Border.

Authors:  Yongjin Qiu; Martin Simuunza; Masahiro Kajihara; Joseph Ndebe; Ngonda Saasa; Penjani Kapila; Hayato Furumoto; Alice C C Lau; Ryo Nakao; Ayato Takada; Hirofumi Sawa
Journal:  Pathogens       Date:  2022-05-10

3.  Genetic Diversity and Sequence Polymorphism of Two Genes Encoding Theileria parva Antigens Recognized by CD8+ T Cells among Vaccinated and Unvaccinated Cattle in Malawi.

Authors:  Elisha Chatanga; Kyoko Hayashida; Walter Muleya; Kodai Kusakisako; Mohamed Abdallah Mohamed Moustafa; Bashir Salim; Ken Katakura; Chihiro Sugimoto; Nariaki Nonaka; Ryo Nakao
Journal:  Pathogens       Date:  2020-04-30

4.  Unique Mitochondrial Single Nucleotide Polymorphisms Demonstrate Resolution Potential to Discriminate Theileria parva Vaccine and Buffalo-Derived Strains.

Authors:  Micky M Mwamuye; Isaiah Obara; Khawla Elati; David Odongo; Mohammed A Bakheit; Frans Jongejan; Ard M Nijhof
Journal:  Life (Basel)       Date:  2020-12-08

5.  Systematic Determination of TCR-Antigen and Peptide-MHC Binding Kinetics among Field Variants of a Theileria parva Polymorphic CTL Epitope.

Authors:  Nicholas Svitek; Rosemary Saya; Houshuang Zhang; Vishvanath Nene; Lucilla Steinaa
Journal:  J Immunol       Date:  2022-01-14       Impact factor: 5.422

6.  Flow Cytometric Analysis of the Cytotoxic T-Cell Recall Response to Theileria parva in Cattle Following Vaccination by the Infection and Treatment Method.

Authors:  Mahmoud M Elnaggar; Donald P Knowles; William C Davis; Lindsay M Fry
Journal:  Vet Sci       Date:  2021-06-18

7.  Development of a Potential Yeast-Based Vaccine Platform for Theileria parva Infection in Cattle.

Authors:  Shan Goh; Jeannine Kolakowski; Angela Holder; Mark Pfuhl; Daniel Ngugi; Keith Ballingall; Kata Tombacz; Dirk Werling
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

8.  Variant analysis of the sporozoite surface antigen gene reveals that asymptomatic cattle from wildlife-livestock interface areas in northern Tanzania harbour buffalo-derived T. parva.

Authors:  Micky M Mwamuye; David Odongo; Yvette Kazungu; Fatuma Kindoro; Paul Gwakisa; Richard P Bishop; Ard M Nijhof; Isaiah Obara
Journal:  Parasitol Res       Date:  2020-10-03       Impact factor: 2.289

9.  Capture-based enrichment of Theileria parva DNA enables full genome assembly of first buffalo-derived strain and reveals exceptional intra-specific genetic diversity.

Authors:  Nicholas C Palmateer; Kyle Tretina; Joshua Orvis; Olukemi O Ifeonu; Jonathan Crabtree; Elliott Drabék; Roger Pelle; Elias Awino; Hanzel T Gotia; James B Munro; Luke Tallon; W Ivan Morrison; Claudia A Daubenberger; Vish Nene; Donald P Knowles; Richard P Bishop; Joana C Silva
Journal:  PLoS Negl Trop Dis       Date:  2020-10-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.